Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,388.56
(
0.31%
)
US TECH 100
22,542.80
(
0.18%
)
Dow Jones
45,507.16
(
0.75%
)
Brent Oil
107.51
(
-0.68%
)
Bitcoin
67,409.64
(
2.20%
)
News Focus
News Focus
Post# of 257307
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122821
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ThomasS post# 65262

Monday, 08/11/2008 6:24:13 PM

Monday, August 11, 2008 6:24:13 PM

Post# of 257307
This is the initial Viread approval in the US for HBV.

http://biz.yahoo.com/bw/080811/20080811006425.html

GILD will now cease promotion of Hepsera for the simple reason that Viread works better.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today